Chimerix, A Jazz Pharmaceuticals Company company information, Employees & Contact Information

Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio PR Newswire

Jazz Pharma Pays 72% Premium for Chimerix: Is This Rare Disease Drug Worth $935M? Stock Titan

Jazz Pharmaceuticals Acquires Chimerix for $935 million Pharmaceutical Executive

Chimerix buyout a win for Jazz with FDA nod for rare glioma drug BioWorld MedTech

Chimerix engaged with 7 other biopharmas before choosing Jazz's $935M deal—here's why it won Fierce Biotech

Is Chimerix Inc. (CMRX) the Best Performing NASDAQ Stock So Far in 2025? Yahoo Finance

Chimerix turns $39m into $935m | ApexOnco - Clinical Trials news and analysis Oncology Pipeline

FDA Grants Priority Review to Dordaviprone in Recurrent H3K27M+ Diffuse Glioma OncLive

Jazz Pharmaceuticals bids for Chimerix in $935m deal Pharmaceutical Technology

Jazz Pharmaceuticals to acquire Chimerix and its experimental brain cancer drug statnews.com

FDA Grants Accelerated Approval to Dordaviprone for H3 K27M-Mutated Diffuse Glioma Oncology Nursing News

Durham drug developer Chimerix agrees to sell for $935 million Business North Carolina

Jazz to Acquire Chimerix for $935M, Expanding Rare Oncology Portfolio Genetic Engineering and Biotechnology News

Jazz Expands Cancer Expertise With $935M Chimerix Buy BioSpace

Chimerix Plans NDA Submission for Dordaviprone in H3 K27M-Mutant Diffuse Glioma, Targeting Q3 2025 Approval Quiver Quantitative

FDA Reviews NDA for Dordaviprone in H3K27M-Mutant Diffuse Glioma Targeted Oncology

Chimerix's cancer transformation | ApexOnco - Clinical Trials news and analysis Oncology Pipeline

Chimerix Inc. (NASDAQ:CMRX) Amazing Performance So Far In 2025 Yahoo Finance

FDA Approval Sought for Dordaviprone in Recurrent H3K27M+ Diffuse Glioma OncLive

Serial CTRS Receives FDA Breakthrough Device Designation for NSCLC Prognosis Oncology Nursing News

Jazz Pharmaceuticals to buy Chimerix for $935 million Reuters

Jazz Offers to Buy Chimerix for $935M to Boost Oncology Portfolio Yahoo Finance

Jazz Pharmaceuticals Completes Acquisition of Chimerix PR Newswire

Why Chimerix, Inc. (CMRX) Soared Last Week Yahoo Finance

Why Is Cancer-Focused Chimerix Stock Trading Higher On Tuesday? Yahoo Finance

Jazz expands in oncology with $935M deal for Chimerix BioPharma Dive

Here’s Why Chimerix, Inc. (CMRX) Is Skyrocketing Yahoo Finance

Chimerix Acquires Oncoceutics to Expand Pipeline with Late-Stage Oncology Program GlobeNewswire

Chimerix gets up to $25.3 million contract from Canada for smallpox drug Reuters

Chimerix Announces Sale of TEMBEXA to Emergent BioSolutions for up to $337.5 Million plus Royalties GlobeNewswire

Jazz strikes the chord with $935m Chimerix acquisition BioXconomy

Jazz hands over $935M to buy Chimerix for near-approval cancer drug Fierce Biotech

Chimerix (CMRX) Stock: Gaining Traction, Cash Runway To 2027 Seeking Alpha

Jazz Buys Chimerix - A Good Deal To Make With Major Approval Catalyst In Play Seeking Alpha

FDA approves targeted brain cancer drug from Jazz’s Chimerix buyout Endpoints News

FDA Accepts New Drug Application for Dordaviprone to Treat Recurrent H3 K27M-Mutant Diffuse Glioma Pharmacy Times

First-in-Class Brain Cancer Drug Strikes a Chord With Jazz Pharma to the Tune of a $935M M&A Deal MedCity News

Chimerix brings a rare cancer drug to the $935M Jazz party BioWorld MedTech

Jazz Pharma to expand oncology portfolio with buy of Chimerix The Pharma Letter

Chimerix Inc.: Is a Breakthrough in Drug Development the Key to a Stock Surge? timothysykes.com

Jazz Pharmaceuticals Acquires Chimerix In $935 Million Deal Finimize

Chimerix climbs on BARDA contract win The Pharma Letter

Chimerix’s CEO departs and is replaced by a trio of officers Fierce Biotech

Chimerix asks FDA to approve oral dordaviprone as glioma treatment Rare Cancer News

Twitter storm forces Chimerix's hand in compassionate use request Nature

A Trump Official Tried to Fast-Track Funding for His Friend’s Unproven COVID-19 “Treatment,” Whistleblower Says ProPublica

Chimerix now 0 for 2 as brincidofovir flunks another PhIII trial Fierce Biotech

Chimerix (CMRX) Stock Price, News & Analysis MarketBeat

Ebola drug maker Chimerix’s stock tumbles after Dallas patient dies Los Angeles Times

Josh Hardy Going Home After Getting Chimerix Anti-Viral Drug Forbes